To answer the question whether CD44 is involved in malignant progress of glioma, we compared its expression level in different WHO grades, IDH types, 1p19q states, and recurrent status in TCGA and CGGA glioma mRNA-seq datasets. The gene discussed is CD44; the disease is central nervous system cancer.